Atlas Trials

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Clinical trial NCT01308437 · TERMINATED

Trial details

NCT number
NCT01308437
Sponsor
Wockhardt
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Type I Diabetes
Start date
2011-03-01
Primary completion
2013-04-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.